Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prognostic factors in multiple sclerosis.

Roberto Bergamaschi1

  • 1Department of Clinical Neurology, Multiple Sclerosis Center, Neurological Institute, C. Mondino, Via Mondino 2, Pavia 27100, Italy.

International Review of Neurobiology
|May 29, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Air pollutants and amyotrophic lateral sclerosis in a population-based registry: investigating disease susceptibility, progression and survival.

Amyotrophic lateral sclerosis & frontotemporal degeneration·2026
Same author

Reduced Childhood Outdoor Exposure Raises Pediatric Multiple Sclerosis (PedMS) Risk.

Neurology and therapy·2026
Same author

Environmental Personal Exposure Clusters to Investigate Multiple Sclerosis and Amyotrophic Lateral Sclerosis Progression.

Studies in health technology and informatics·2026
Same author

Ozone pollution as a possible trigger for multiple sclerosis in young people: the PEDIGREE study.

Journal of neurology·2026
Same author

Reducing Early-Life Smoke Exposure as a Preventive Strategy for Pediatric Multiple Sclerosis: Results from the PEDIGREE Study.

Neurology and therapy·2026
Same author

The association of environmental exposure with multiple sclerosis severity score: A study based on sequential data modeling.

International journal of medical informatics·2026
Same journal

Glutamate-Glutamine metabolism and transport, implications in Parkinson's disease.

International review of neurobiology·2026
Same journal

Redox bioenergetics of neuronal senescence in Alzheimer's disease.

International review of neurobiology·2026
Same journal

Neurovascular coupling and energy substrate delivery in Alzheimer's disease.

International review of neurobiology·2026
Same journal

From metals to mitochondria: Linking trace elements to energy crisis in Alzheimer's disease.

International review of neurobiology·2026
Same journal

Invisible threats of microplastics induced toxicity: Oxidative and inflammatory pathways in the CNS and retina.

International review of neurobiology·2026
Same journal

Starved synapses: Gut microbiome dysbiosis and its role in Alzheimer's glucose impairment.

International review of neurobiology·2026
See all related articles

Identifying prognostic factors for multiple sclerosis (MS) is crucial for patient counseling and guiding early treatment decisions. Key indicators include male gender, late onset, and early disability progression, supported by MRI findings.

Area of Science:

  • Neurology
  • Immunology
  • Clinical Research

Background:

  • Prognostic factors are vital for informing patients about multiple sclerosis (MS) progression.
  • Clinicians require these factors to identify patients suitable for immune treatments.
  • Researchers need prognostic indicators to refine clinical trial design and analysis.

Purpose of the Study:

  • To highlight the importance of prognostic factors in multiple sclerosis (MS).
  • To identify clinical and paraclinical predictors for MS prognosis.
  • To emphasize the need for reliable predictors for early and aggressive therapy decisions.

Main Methods:

  • Review of existing studies on multiple sclerosis (MS) prognostic factors.
  • Analysis of clinical indicators such as gender, age at onset, and initial symptoms.

Related Experiment Videos

  • Evaluation of paraclinical methods including MRI, CSF analysis, and evoked potentials.

    • Main Results:

    • Poor prognosis in MS is associated with male gender, late age at onset, motor/cerebellar/sphincter involvement, progressive course, short inter-attack interval, and early residual disability.
    • Imaging techniques, cerebrospinal fluid analysis, and evoked potentials provide paraclinical support for MS prognosis.
    • MRI is the most sensitive paraclinical test for predicting conversion to definite MS.

    Conclusions:

    • Accurate prognostic factors are essential for personalized MS management and treatment strategies.
    • Early identification of patients with poor prognosis can facilitate timely and aggressive therapeutic interventions.
    • MRI demonstrates significant utility in predicting MS development from suspected demyelinating disease.